Knowthestock.com
DRAD - Digirad Corp.

Sell

Weak GrowthEarnings/Profit is Negative

19%

based on last 5 year data.
Income Statement is WEAK
Revenue Growth is 14.14%
Operating Income is Negative
Net Income is Negative
Earnings Per Share (EPS) is Negative
Net Margin is -6.54%
Balance Sheet is MODERATE
Current Asset to Current Liability Ratio is 1.36
Debt Ratio is 0.53
Current Debt to Net Income Ratio not available
Total Debt to Total Assets Ratio is 0.03
Cash Flow is WEAK
Cash from Operations Growth is -98.01%
Capital Expenditure not available
Net Increase in Cash is Positive
Long Term Score Trend is NEGATIVE
Investment Risk is High
based on last 4 quarter data.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Digirad Corp. (DRAD) - http://www.digirad.com
Digirad Corp. engages in the provision of healthcare solutions. It operates through the following segments: Diagnostic Services, Mobile Healthcare, Diagnostic Imaging, Building and Construction and Real Estate and Investments. The Diagnostic Services segment offers imaging and monitoring services program for purchasing equipment or outsourcing the procedures to another physician or imaging center. The Mobile Healthcare segment provides contract diagnostic imaging, including computerized tomography, magnetic resonance imaging, positron emission tomography, PET/CT and nuclear medicine and healthcare to hospitals, delivery networks and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. The Diagnostic Imaging segment sells internally developed solid-state gamma cameras, imaging systems and camera maintenance contracts. The Building and Construction segment provides residential and commercial construction projects by manufacturing modular housing units and other products and supplies general contractors with building materials. The Real Estate and Investments segment manages real estate assets and investments. The company was founded in 1997 and is headquartered in Suwanee, GA.
Exchange - NASDAQ
Industry - Medical Specialties
Sector - Health Technology
CEO - Matthew Gabel Molchan
Employees - 618
    Close


Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2021 and future.